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Background
The HIV-1 viral envelope originates from the cell mem-
brane and contains different cellular proteins such as
MHC class I molecules, which play a role in modulating
viral infectivity. HLA-C is known to enhance viral infectiv-
ity and reduce sensitivity to neutralizing antibodies by
inducing gp120/41 conformational changes that may
increase fusion efficiency and viral infectivity [1]. In this
work we studied the effect of HLA-C on syncytia forma-
tion and of its association with the HIV-1 gp120/41 and
with the CD4/CCR5 receptors in purified fusion com-
plexes.
Materials and methods
Syncytia were formed by co-cultivating HeLa cells express-
ing the HIV-1 gp120/41 of different laboratory and pri-
mary isolates with target cells expressing HIV-1 receptors
(3T3.T4.CCR5; 3T3.T4.CXCR4; HeLa-P4.2; TZM-bl;
CHO-CD4-CCR5). HLA-C expression was silenced using
the RNA interference technique (Dharmacon SMARTpool
siRNAs) and verified by Western blot and cytofluorimetry.
Fusion efficiency was determined by calculating the
fusion index, and, with TZM-bl cells, by using the β-gal
and the luciferase quantitative assays. Fusion complexes
formed by co-cultivating CHO-gp120/41-HLA-C and
CHO-CD4-CCR5 cells, and by co-cultivating CHO-
gp120/41 and CHO-CD4-CCR5-HLA-C cells were puri-
fied and analyzed by Western blot and dot-blot as
described [2].
Results
The level of syncytia formation between HLA-C silenced
HeLa-ADA and 3T3.T4.CCR5 cells or HeLa-LAI and
3T3.T4.CXCR4 cells was significantly lower (p < 0.01)
than between non silenced control and target receptor
cells. The R5-tropic gp120/41 ADA was sensitive to HLA-
C presence when fusing with 3T3.T4.CXCR4 cells (p <
0.01), whereas the X4-tropic gp120/41 LAI was not
affected by HLA-C presence when fusing with
3T3.T4.CCR5 cells. Similarly, fusion efficiency was signif-
icantly lower (p < 0.01) using HLA-C silenced cells
expressing HIV-1 gp120/41s with either HeLa-P4.2 or
TZM-bl cells. No difference was evident using gp120/41 of
the NDK isolate, confirming a previous report [1]. When
HLA-C was expressed on target receptors cells, a similar
positive effect on fusion efficiency was observed for all
gp120/41s tested, including NDK. HLA-C molecules were
detected in purified fusion complexes, either associated
with the gp120/41 or with the receptors.
Conclusion
HLA-C silencing by RNA interference reduces fusion effi-
ciency of X4 and R5-tropic gp120/41s, highlighting its
role in increasing viral infectivity. The fusion efficiency of
R5-tropic gp120/41 with CD4-CXCR4 cells is enhanced
by HLA-C presence, whereas the X4-tropic gp120/41 LAI
is not sensitive to HLA-C presence when fusing with CD4-
CCR5 cells, suggesting that HLA-C might play a role in the
transition from R5 to X4-tropism during the course of nat-
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ural infection. The NDK env fusion capacity is not influ-
enced by HLA-C presence when co-expressed with the
gp120/41, but it is enhanced when HLA-C is co-expressed
with the receptors, suggesting a different mechanism of
action for HLA-C molecules in enhancing viral infectivity,
whether they are expressed on the same membrane that
contains the gp120/41 or expressed with the receptors.
The comparison between HLA-C sensitive and insensitive
gp120/41 sequences may help elucidating the role of
HLA-C in the fusion process by indicating a possible inter-
action and/or association between these molecules. The
co-purification of HLA-C with the fusion complex sug-
gests its association either with gp120/41 or with HIV-1
cellular receptor/co-receptor, resulting in an increased
efficiency of the fusion process and thus a greater infectiv-
ity of viral particles that include HLA-C in their envelope.
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